Selected research
Market Structure
Global Clinical Pathology AI Software Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Clinical Pathology AI Software market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for Clinical Pathology AI Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Clinical Pathology AI Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Clinical Pathology AI Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Clinical Pathology AI Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Clinical Pathology AI Software include PathAI, Proscia, Aiforia, Deep Bio, Hologic, Dipath, iDeepwise, LBP and F.Q pathtech, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global Clinical Pathology AI Software market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Clinical Pathology AI Software and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Clinical Pathology AI Software revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Clinical Pathology AI Software market size, projected growth trends, production technologies, key applications, and end-use industries.
Clinical Pathology AI Software Segment by Company
PathAI
Proscia
Aiforia
Deep Bio
Hologic
Dipath
iDeepwise
LBP
F.Q pathtech
CellaVision
AIRA Matrix
Syntropy
Indica Labs
DoMore Diagnostics
Mindpeak
Evidium
Clinical Pathology AI Software Segment by Type
Cloud-Based
On-Premise
Clinical Pathology AI Software Segment by Application
Hospital
Diagnostic Centers
Laboratories & Research Institutes
Clinical Pathology AI Software Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Clinical Pathology AI Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Clinical Pathology AI Software and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Clinical Pathology AI Software.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Clinical Pathology AI Software in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Clinical Pathology AI Software industry.
Chapter 3: Detailed analysis of Clinical Pathology AI Software companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Clinical Pathology AI Softwarerevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Cloud-Based
- On-Premise
Applications
- Hospital
- Diagnostic Centers
- Laboratories & Research Institutes
Companies covered
- PathAI
- Proscia
- Aiforia
- Deep Bio
- Hologic
- Dipath
- iDeepwise
- LBP
- F.Q pathtech
- CellaVision
- AIRA Matrix
- Syntropy
- Indica Labs
- DoMore Diagnostics
- Mindpeak
- Evidium
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Clinical Pathology AI Software Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Cloud-Based
- 1.2.3 On-Premise
- 1.3 Market Analysis by Application
- 1.3.1 Global Clinical Pathology AI Software Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Hospital
- 1.3.3 Diagnostic Centers
- 1.3.4 Laboratories & Research Institutes
- 1.4 Global Market Growth Prospects
- 1.5 Global Clinical Pathology AI Software Growth Trends by Region
- 1.5.1 Global Clinical Pathology AI Software Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Clinical Pathology AI Software Market Size by Region (2021-2026)
- 1.5.3 Clinical Pathology AI Software Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Clinical Pathology AI Software Market Dynamics
- 2.1 Clinical Pathology AI Software Industry Trends
- 2.2 Clinical Pathology AI Software Industry Drivers
- 2.3 Clinical Pathology AI Software Industry Opportunities and Challenges
- 2.4 Clinical Pathology AI Software Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Clinical Pathology AI Software Revenue by Company (2021-2026)
- 3.2 Global Clinical Pathology AI Software Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Clinical Pathology AI Software Key Company Head office and Area Served
- 3.4 Global Clinical Pathology AI Software Company, Product Type & Application
- 3.5 Global Clinical Pathology AI Software Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Clinical Pathology AI Software Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Clinical Pathology AI Software Players Market Share by Revenue in 2025
- 3.6.3 2025 Clinical Pathology AI Software Tier 1, Tier 2, and Tier 3
4 Clinical Pathology AI Software Market by Type
- 4.1 Global Clinical Pathology AI Software Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Clinical Pathology AI Software Market Size by Type (2021-2032)
- 4.3 Global Clinical Pathology AI Software Market Size Share by Type (2021-2032)
5 Clinical Pathology AI Software Market by Application
- 5.1 Global Clinical Pathology AI Software Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Clinical Pathology AI Software Market Size by Application (2021-2032)
- 5.3 Global Clinical Pathology AI Software Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 PathAI
- 6.1.1 PathAI Company Information
- 6.1.2 PathAI Business Overview
- 6.1.3 PathAI Clinical Pathology AI Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 PathAI Clinical Pathology AI Software Product Portfolio
- 6.1.5 PathAI Recent Developments
- 6.2 Proscia
- 6.2.1 Proscia Company Information
- 6.2.2 Proscia Business Overview
- 6.2.3 Proscia Clinical Pathology AI Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 Proscia Clinical Pathology AI Software Product Portfolio
- 6.2.5 Proscia Recent Developments
- 6.3 Aiforia
- 6.3.1 Aiforia Company Information
- 6.3.2 Aiforia Business Overview
- 6.3.3 Aiforia Clinical Pathology AI Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 Aiforia Clinical Pathology AI Software Product Portfolio
- 6.3.5 Aiforia Recent Developments
- 6.4 Deep Bio
- 6.4.1 Deep Bio Company Information
- 6.4.2 Deep Bio Business Overview
- 6.4.3 Deep Bio Clinical Pathology AI Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 Deep Bio Clinical Pathology AI Software Product Portfolio
- 6.4.5 Deep Bio Recent Developments
- 6.5 Hologic
- 6.5.1 Hologic Company Information
- 6.5.2 Hologic Business Overview
- 6.5.3 Hologic Clinical Pathology AI Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 Hologic Clinical Pathology AI Software Product Portfolio
- 6.5.5 Hologic Recent Developments
- 6.6 Dipath
- 6.6.1 Dipath Company Information
- 6.6.2 Dipath Business Overview
- 6.6.3 Dipath Clinical Pathology AI Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 Dipath Clinical Pathology AI Software Product Portfolio
- 6.6.5 Dipath Recent Developments
- 6.7 iDeepwise
- 6.7.1 iDeepwise Company Information
- 6.7.2 iDeepwise Business Overview
- 6.7.3 iDeepwise Clinical Pathology AI Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 iDeepwise Clinical Pathology AI Software Product Portfolio
- 6.7.5 iDeepwise Recent Developments
- 6.8 LBP
- 6.8.1 LBP Company Information
- 6.8.2 LBP Business Overview
- 6.8.3 LBP Clinical Pathology AI Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 LBP Clinical Pathology AI Software Product Portfolio
- 6.8.5 LBP Recent Developments
- 6.9 F.Q pathtech
- 6.9.1 F.Q pathtech Company Information
- 6.9.2 F.Q pathtech Business Overview
- 6.9.3 F.Q pathtech Clinical Pathology AI Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 F.Q pathtech Clinical Pathology AI Software Product Portfolio
- 6.9.5 F.Q pathtech Recent Developments
- 6.10 CellaVision
- 6.10.1 CellaVision Company Information
- 6.10.2 CellaVision Business Overview
- 6.10.3 CellaVision Clinical Pathology AI Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 CellaVision Clinical Pathology AI Software Product Portfolio
- 6.10.5 CellaVision Recent Developments
- 6.11 AIRA Matrix
- 6.11.1 AIRA Matrix Company Information
- 6.11.2 AIRA Matrix Business Overview
- 6.11.3 AIRA Matrix Clinical Pathology AI Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.11.4 AIRA Matrix Clinical Pathology AI Software Product Portfolio
- 6.11.5 AIRA Matrix Recent Developments
- 6.12 Syntropy
- 6.12.1 Syntropy Company Information
- 6.12.2 Syntropy Business Overview
- 6.12.3 Syntropy Clinical Pathology AI Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.12.4 Syntropy Clinical Pathology AI Software Product Portfolio
- 6.12.5 Syntropy Recent Developments
- 6.13 Indica Labs
- 6.13.1 Indica Labs Company Information
- 6.13.2 Indica Labs Business Overview
- 6.13.3 Indica Labs Clinical Pathology AI Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.13.4 Indica Labs Clinical Pathology AI Software Product Portfolio
- 6.13.5 Indica Labs Recent Developments
- 6.14 DoMore Diagnostics
- 6.14.1 DoMore Diagnostics Company Information
- 6.14.2 DoMore Diagnostics Business Overview
- 6.14.3 DoMore Diagnostics Clinical Pathology AI Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.14.4 DoMore Diagnostics Clinical Pathology AI Software Product Portfolio
- 6.14.5 DoMore Diagnostics Recent Developments
- 6.15 Mindpeak
- 6.15.1 Mindpeak Company Information
- 6.15.2 Mindpeak Business Overview
- 6.15.3 Mindpeak Clinical Pathology AI Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.15.4 Mindpeak Clinical Pathology AI Software Product Portfolio
- 6.15.5 Mindpeak Recent Developments
- 6.16 Evidium
- 6.16.1 Evidium Company Information
- 6.16.2 Evidium Business Overview
- 6.16.3 Evidium Clinical Pathology AI Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.16.4 Evidium Clinical Pathology AI Software Product Portfolio
- 6.16.5 Evidium Recent Developments
7 North America
- 7.1 North America Clinical Pathology AI Software Market Size (2021-2032)
- 7.2 North America Clinical Pathology AI Software Market Size by Type
- 7.2.1 North America Clinical Pathology AI Software Market Size by Type (2021-2026)
- 7.2.2 North America Clinical Pathology AI Software Market Size by Type (2027-2032)
- 7.2.3 North America Clinical Pathology AI Software Market Share by Type (2021-2032)
- 7.3 North America Clinical Pathology AI Software Market Size by Application
- 7.3.1 North America Clinical Pathology AI Software Market Size by Application (2021-2026)
- 7.3.2 North America Clinical Pathology AI Software Market Size by Application (2027-2032)
- 7.3.3 North America Clinical Pathology AI Software Market Share by Application (2021-2032)
- 7.4 North America Clinical Pathology AI Software Market Size by Country
- 7.4.1 North America Clinical Pathology AI Software Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Clinical Pathology AI Software Market Size by Country (2021-2026)
- 7.4.3 North America Clinical Pathology AI Software Market Size by Country (2027-2032)
- 7.4.4 North America Clinical Pathology AI Software Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Clinical Pathology AI Software Market Size (2021-2032)
- 8.2 Europe Clinical Pathology AI Software Market Size by Type
- 8.2.1 Europe Clinical Pathology AI Software Market Size by Type (2021-2026)
- 8.2.2 Europe Clinical Pathology AI Software Market Size by Type (2027-2032)
- 8.2.3 Europe Clinical Pathology AI Software Market Share by Type (2021-2032)
- 8.3 Europe Clinical Pathology AI Software Market Size by Application
- 8.3.1 Europe Clinical Pathology AI Software Market Size by Application (2021-2026)
- 8.3.2 Europe Clinical Pathology AI Software Market Size by Application (2027-2032)
- 8.3.3 Europe Clinical Pathology AI Software Market Share by Application (2021-2032)
- 8.4 Europe Clinical Pathology AI Software Market Size by Country
- 8.4.1 Europe Clinical Pathology AI Software Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Clinical Pathology AI Software Market Size by Country (2021-2026)
- 8.4.3 Europe Clinical Pathology AI Software Market Size by Country (2027-2032)
- 8.4.4 Europe Clinical Pathology AI Software Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Clinical Pathology AI Software Market Size (2021-2032)
- 9.2 China Clinical Pathology AI Software Market Size by Type
- 9.2.1 China Clinical Pathology AI Software Market Size by Type (2021-2026)
- 9.2.2 China Clinical Pathology AI Software Market Size by Type (2027-2032)
- 9.2.3 China Clinical Pathology AI Software Market Share by Type (2021-2032)
- 9.3 China Clinical Pathology AI Software Market Size by Application
- 9.3.1 China Clinical Pathology AI Software Market Size by Application (2021-2026)
- 9.3.2 China Clinical Pathology AI Software Market Size by Application (2027-2032)
- 9.3.3 China Clinical Pathology AI Software Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Clinical Pathology AI Software Market Size (2021-2032)
- 10.2 Asia Clinical Pathology AI Software Market Size by Type
- 10.2.1 Asia Clinical Pathology AI Software Market Size by Type (2021-2026)
- 10.2.2 Asia Clinical Pathology AI Software Market Size by Type (2027-2032)
- 10.2.3 Asia Clinical Pathology AI Software Market Share by Type (2021-2032)
- 10.3 Asia Clinical Pathology AI Software Market Size by Application
- 10.3.1 Asia Clinical Pathology AI Software Market Size by Application (2021-2026)
- 10.3.2 Asia Clinical Pathology AI Software Market Size by Application (2027-2032)
- 10.3.3 Asia Clinical Pathology AI Software Market Share by Application (2021-2032)
- 10.4 Asia Clinical Pathology AI Software Market Size by Country
- 10.4.1 Asia Clinical Pathology AI Software Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Clinical Pathology AI Software Market Size by Country (2021-2026)
- 10.4.3 Asia Clinical Pathology AI Software Market Size by Country (2027-2032)
- 10.4.4 Asia Clinical Pathology AI Software Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Clinical Pathology AI Software Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Clinical Pathology AI Software Market Size by Type
- 11.2.1 South America, Middle East & Africa Clinical Pathology AI Software Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Clinical Pathology AI Software Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Clinical Pathology AI Software Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Clinical Pathology AI Software Market Size by Application
- 11.3.1 South America, Middle East & Africa Clinical Pathology AI Software Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Clinical Pathology AI Software Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Clinical Pathology AI Software Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Clinical Pathology AI Software Market Size by Country
- 11.4.1 South America, Middle East & Africa Clinical Pathology AI Software Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Clinical Pathology AI Software Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Clinical Pathology AI Software Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Clinical Pathology AI Software Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst